https://orcid.org/0000-0002-2045-9324
Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Bela Shah, Deval Mistry, Dharmender Jairam, Kajal Kansara, Rutvi Pandya, Presha Vasani, Dhiraj Dhoot, Namrata Mahadkar, Sumit Bhushan & Hanmant Barkate. (2023) Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea. Infection and Drug Resistance 16, pages 2409-2416.
Read now
Read now
Manjunath M Shenoy, Abhishek De, Bela Shah, Anupam Das, Abir Saraswat, Koushik Lahiri, Sheetal Yadav, Aarti Sarda, Disha Chakraborty, Dharmender J, Shruti Kamat, Yashika Doshi, Nelry Gonsalves, Ankita Choudhary, Dhiraj Dhoot, Namrata Mahadkar, Sumit Bhushan, Rujuta Gadkari & Hanmant Barkate. (2023) Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial. Drug Design, Development and Therapy 17, pages 2899-2908.
Read now
Read now
Articles from other publishers (3)
Ramesh M. Bhat, Monisha Madhumita & Jyothi Jayaraman. (2022)
Dermatophytoses Severity Score
– A novel point‐of‐care scoring tool to assess the severity of dermatophytosis
. Mycoses 66:4, pages 354-361.
Crossref
Crossref
S. Handa, A. Villasis-Keever, M. Shenoy, S. Anandan, M. Bhrushundi, N. Garodia, D. Fife, P. De Doncker, K. Shalayda, P. Hu, S. Fonseca & N. Cure-bolt. (2023) No evidence of resistance to itraconazole in a prospective real-world trial of dermatomycosis in India. PLOS ONE 18:2, pages e0281514.
Crossref
Crossref
Aparajita Ghosh & Saumya Panda. (2023) Evidence-based management of dermatophytosis in India today. Apollo Medicine 20:1, pages 32.
Crossref
Crossref